A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.
Dranoff
G
G
Dana-Farber Cancer Institute, Boston, MA, USA.
Soiffer
R
R
Lynch
T
T
Mihm
M
M
Jung
K
K
Kolesar
K
K
Liebster
L
L
Lam
P
P
Duda
R
R
Mentzer
S
S
Singer
S
S
Tanabe
K
K
Johnson
R
R
Sober
A
A
Bhan
A
A
Clift
S
S
Cohen
L
L
Parry
G
G
Rokovich
J
J
Richards
L
L
Drayer
J
J
Berns
A
A
Mulligan
R C
RC
D005818:Genetic Engineering; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008545:Melanoma / Q000378:metabolism / Q000628:therapy*; D018579:Patient Selection; D013223:Statistics as Topic; D014407:Tumor Cells, Cultured; D014611:Vaccination
D016178:Granulocyte-Macrophage Colony-Stimulating Factor